Samuel Hahnemann (1755-1843), born at Meissen in Saxony and a medical graduate of Erlangen (1779), was a learned physician, chemist, and medical translator who set himself against the heroic purging and bleeding of his day. Around the mid-1790s he reported that regular doses of cinchona bark (the source of quinine) produced in him, while healthy, symptoms resembling the intermittent fever the bark was used to treat. From this self-experiment he drew a general rule, which he first published in 1796 in Christoph Wilhelm Hufeland's Journal der practischen Arzneykunde und Wundarzneykunst (the same periodical in which Hufeland would publish Kant's open letter on macrobiotics) and systematized in the Organon der rationellen Heilkunde (Dresden: Arnold, 1810). What carried homeopathy was not a clinic or a proprietary substance but a doctrine, a foundational book, and Hahnemann's standing as a reformer offering a gentler alternative to a genuinely harmful contemporary medicine (Loudon 2006; Haehl 1922).
[2] EXCLUSIVE ACCESS
As with the contemporary Hufeland macrobiotics case, the intervention was not itself scarce: the remedies were inexpensive and the system was published in a book any literate reader could buy, and it spread through trained practitioners across Europe. Exclusivity attached to the practitioner rather than to the product. Hahnemann's personal practice was the premium access point, above all the lucrative Paris clinic of his final years. He married his second wife, Mélanie d'Hervilly, in 1835, moved to Paris, and practised there until his death (Mix and Cameron 2011); Loudon records that he 'died a millionaire in Paris in 1843'. The structure matches Hufeland and Metchnikoff, where a cheap or freely published base was monetized through the authority and clientele of the promoter, not the cost of the thing itself.
[3] VAGUE MECHANISM
Homeopathy rests on two propositions and a vitalist premise, and on no measured endpoint. The first is the law of similars: a drug that produces a symptom-picture in a healthy prover is the remedy for a disease of like symptoms (similia similibus curentur). The second is the law of infinitesimals: that serial dilution accompanied by vigorous shaking, a process Hahnemann named potentization, develops a remedy's curative power even as it reduces the material dose toward nothing, the diluted medicine persisting (in Loudon's phrase) as a 'dematerialized spiritual force'. Both act, in the doctrine, on the vital force (Lebenskraft), the same vitalist principle that anchors the Hufeland case. The evidence offered was Hahnemann's drug 'provings' (symptom records from dosing the healthy) and cured-case reports, neither of which separates a specific effect from the natural course of illness or from expectation. Neither a surrogate nor a hard endpoint was measured. The mechanism also collides with chemistry: past roughly the twelfth centesimal step (12C, about 10^-24, or 24X), the Avogadro constant makes it improbable that a dose contains even one molecule of the starting substance (Bellavite et al. 2005).
[4] FINANCIAL CONFLICT
The conflict is the authorial-and-practice-income pattern rather than the developer-vendor model, and it is named from documented facts. Hahnemann earned his living from a fee-charging medical practice that became lucrative in his Paris years, and he held a direct authorial interest in the Organon, the foundational text of the system he originated, which ran through six editions and many translations. He profited, through both an elite practice and a much-reprinted book, from a doctrine resting on his own provings and case reports rather than on controlled evidence, whose central high-dilution claim had been contradicted under blinded test within his lifetime. Loudon's history records that he died a millionaire in Paris in 1843. The characterization is held to what the sources support: a fee-charging practice and a much-reprinted book have many other costs and recipients of income, so the conflict is named as personal enrichment from his practice and his book, not as exclusive command of homeopathy's income.
[5] DISCONFIRMATION / COLLAPSE
Homeopathy is unusual in this archive in having faced an early, explicit, controlled disconfirmation. In 1835 the senior Nuremberg public health official Friedrich Wilhelm von Hoven, prompted by the local homeopath Johann Jacob Reuter's challenge over a C30 dilution of common salt, organized the Nuremberg salt test: a hundred numbered vials, fifty holding distilled snow water and fifty the C30 salt dilution, were shuffled and distributed so that neither the participants nor the organizers knew which was which. Of the fifty who reported back, eight noticed anything unusual, split five to three between the dilution and plain water, a result read as no effect attributable to the remedy and an early instance of the blinded comparison later formalized as the randomized double-blind trial (Stolberg 2006). The modern verdict converges: a 2005 comparative meta-analysis in The Lancet concluded that homeopathy's clinical effects are compatible with placebo (Shang et al. 2005), and the dilution doctrine is inconsistent with the Avogadro limit (Bellavite et al. 2005). The evidence for a specific, beyond-placebo action is insufficient, and is labelled insufficient. The case is atypical in one respect worth stating plainly: because the high dilutions are materially inert, the harm was not toxic, and in its own period the system spared patients the active injury of heroic purging and bleeding; what was disconfirmed was the specific curative claim, not a claim of poisoning.
OUTCOME
Homeopathy is the founding case in this archive of a longevity-adjacent therapeutic doctrine sold on a charismatic practitioner, a book, and an unmeasurable mechanism, and the earliest case in which the disconfirming method outlived the doctrine. Hahnemann generalized a single self-experiment with cinchona into the law of similars (1796) and added the law of infinitesimals in the Organon (1810): that dilution with succussion develops a curative power persisting past the point where any molecule of the original substance remains, acting on the vital force. No endpoint was measured; the evidence was provings and case reports, which is insufficient, and the high-dilution claim is contradicted both by the Avogadro limit and by direct test. That test, the Nuremberg salt test of 1835, is the historically important thing here: a blinded, randomized public comparison of a C30 salt dilution against distilled water that found no difference, anticipating the randomized double-blind trial. A 2005 Lancet meta-analysis reached the same conclusion across the modern trial record. Hahnemann died a millionaire in Paris in 1843. The structural pattern, a non-measurable mechanism converted into a marketed practice without hard-endpoint evidence, runs straight into the contemporary Hufeland vitalism, the placebo logic of Perkins's tractors and Mesmer's blinded royal commission, and forward into present-day longevity marketing.
FIGURES
FIG 1Homeopathic medicine chest, Europe, 19th century. Wellcome Collection (CC BY 4.0). (1850)LICENSEDsourceFIG 2Samuel Christian Friedrich Hahnemann. Plaster bust by P.-J. David d'Angers, 1837. Wellcome Collection. (1837)PUBLIC DOMAINsource
Samuel Hahnemann (1755-1843) founded homeopathy on a single self-experiment and a rule drawn from it. Trained at Erlangen (medical degree 1779) and working as a physician and medical translator, he reported in the mid-1790s that doses of cinchona bark produced fever-like symptoms in him while he was healthy, and inferred that a drug which produces a symptom-picture in the healthy is the drug to cure a disease of like symptoms. He published this principle of similars in 1796 in Hufeland’s Journal der practischen Arzneykunde und Wundarzneykunst, the leading German medical periodical of the day and, as it happens, the same journal that carried Kant’s open letter on Hufeland’s macrobiotics. He gave the system its complete statement in the Organon der rationellen Heilkunde (Dresden: Arnold, 1810), adding the law of infinitesimals: that serial dilution with succussion (potentization) develops a remedy’s power while reducing its material dose, the medicine persisting, in Loudon’s phrase, as a “dematerialized spiritual force” acting on the vital force (Lebenskraft).
This case is the contemporary of Hufeland’s macrobiotics (1797) and of Elisha Perkins’s metallic tractors (patented 1796), and it sits in the same speculative-mechanism family as Mesmer’s animal magnetism, whose Paris peak the blinded royal commission of 1784 had already addressed. What distinguishes homeopathy is that its central claim met an early, explicit, controlled test. In 1835 the senior Nuremberg public health official Friedrich Wilhelm von Hoven, answering the local homeopath Johann Jacob Reuter’s challenge over a C30 dilution of common salt, organized what is now called the Nuremberg salt test: a hundred numbered vials, half distilled snow water and half the C30 dilution, shuffled and handed out so that neither participants nor organizers knew which was which. Of the fifty who reported back, eight noticed anything unusual, five from the dilution group and three from the water, and the organizers concluded the remedy had no effect (Stolberg 2006). The episode is an early instance of the blinded, randomized comparison later formalized as the double-blind trial.
The doctrine’s economics follow the pattern of the Hufeland case rather than the developer-vendor model. The remedies were cheap and the system was published in books, but Hahnemann’s authority and his practice were the premium asset, above all the lucrative Paris clinic of his final years; he married Mélanie d’Hervilly in 1835, moved to Paris, completed the sixth edition of the Organon there in 1842 (published only in 1921), and, in Loudon’s words, “died a millionaire in Paris in 1843” (Mix and Cameron 2011; Loudon 2006). The conflict is named only as far as the sources reach: he profited from an elite practice and a much-reprinted book built on a doctrine whose central claim rested on provings and case reports and had been contradicted under test.
The case is atypical for this archive in that the harm was not toxic. Because high dilutions are materially inert, homeopathy did not poison its patients the way radium tonic or testicular grafting could, and in its own century it spared people the active injury of heroic purging and bleeding. What was disconfirmed was the specific curative claim, not a claim of harm: the dilution doctrine is inconsistent with the Avogadro limit (Bellavite et al. 2005), the one high dilution put to controlled test in 1835 behaved like water, and a 2005 Lancet meta-analysis found the modern clinical signal compatible with placebo (Shang et al. 2005). The evidence for a specific, beyond-placebo action is insufficient, and the archive labels it insufficient. The lasting significance of the case is the method it provoked: the blinded, randomized comparison that homeopathy’s bolder claims invited, and failed.
